Panel Discussion: Embedding Mental Health into Biopharma EHS Culture

12:00 pm - Thursday 26th March 2026

  • How can data on fatigue, ergonomics, and incident trends be used to make a compelling business case for mental health investment in biopharma?
  • How can EHS teams meaningfully integrate mental health and stress management into existing safety programmes without diluting their core mission?
  • What practical interventions, from workload design to leadership training, have proven most effective in preventing burnout and promoting psychological safety on site?

Speakers:

Director, Safety, Health & Environmental
AstraZeneca
Executive Director, Global Occupational Health, Environment Health & Safety
Amgen
Networks Senior Leader
National Safety Council
Environmental Health & Safety Lead
New England BioLabs